Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles

Open access

Abstract

BACKGROUND: Azole resistance is an emerging problem in Aspergillus fumigatus and complicates the management of patients with Aspergillus-related diseases. Selection of azole resistance may occur through exposure to azole fungicides in the environment. In the Netherlands a surveillance network was used to investigate the epidemiology of resistance selection in A. fumigatus. METHODS: Clinical A. fumigatus isolates were screened for azole resistance in 8 university hospitals using azole agar dilution plates. Patient information was collected using an online questionnaire and azole-resistant A. fumigatus isolates were analyzed using gene sequencing, susceptibility testing, and genotyping. Air sampling was performed to investigate the presence of resistant isolates in hospitals and domiciles. RESULTS: Between December 2009 and January 2011, 1315 A. fumigatus isolates from 921 patients were screened. A new cyp51A-mediated resistance mechanism (TR46/Y121F/T289A) was observed in 21 azole-resistant isolates from 15 patients in 6 hospitals. TR46/Y121F/T289A isolates were highly resistant to voriconazole (minimum inhibitory concentration ≥16 mg/L). Eight patients presented with invasive aspergillosis due to TR46/Y121F/T289A, and treatment failed in all 5 patients receiving primary therapy with voriconazole. TR46/Y121F/T289A Aspergillus fumigatus was recovered from 6 of 10 sampled environmental sites. CONCLUSIONS: We describe the emergence and geographical migration of a voriconazole highly resistant A. fumigatus that was associated with voriconazole treatment failure in patients with invasive aspergillosis. Recovery of TR46/Y121F/T289A from the environment suggests an environmental route of resistance selection. Exposure of A. fumigatus to azole fungicides may facilitate the emergence of new resistance mechanisms over time, thereby compromising the use of azoles in the management of Aspergillus-related diseases.

Overview

Integrity signals

Registry

Crossref · 10.1093/cid/cit320

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. Van der Linden, 2009, Azole containing agar plates as a screening tool for azole resistance of Aspergillus fumigatus, Mycoses, 52, S1

Cited by

See all 349

Metadata

Authors
van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., Karawajczyk, A., Zoll, J., Melchers, W. J. G., & Verweij, P. E.
Affiliations
  • Radboud University Nijmegen (NL)
  • University Medical Center Groningen (NL)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • University Medical Center Utrecht (NL)
  • Erasmus MC (NL)
  • Leiden University Medical Center (NL)
  • University of Szeged (HU)
  • Radboud University Medical Center (NL)
Venue
Clinical Infectious Diseases
Published
2013-05-10
Volume
57
Issue
4
Pages
513-520
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2142912010
Cited by
342
References
31
Citations by year
2026: 5 · 2025: 17 · 2024: 15 · 2023: 21 · 2022: 13 · 2021: 28 · 2020: 25 · 2019: 21 · 2018: 32 · 2017: 38 · 2016: 38 · 2015: 40 · 2014: 34 · 2013: 13
FWCI
30.27
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
  • Pfizer
  • Gilead Sciences
  • ZonMw
  • Astellas Pharma
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords
Aspergillus fumigatus, voriconazole resistance, azole resistance, invasive aspergillosis, cyp51A mutations, azole fungicides, environmental isolates, treatment failure, antifungal resistance surveillance
MeSH terms
Aged, Air Microbiology, Antifungal Agents, Aspergillosis, Aspergillus fumigatus, Child, Female, Genes, Fungal, Genotype, Hospitals, Humans, Male, Middle Aged, Netherlands, Pyrimidines, Surveys and Questionnaires, Residence Characteristics, Selection, Genetic, Triazoles, Mycological Typing Techniques, Treatment Failure, Sequence Analysis, DNA, Drug Resistance, Fungal, Young Adult, Molecular Typing, Voriconazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles. https://app.cochat.ai/papers/10.1093/cid/cit320
The paper
van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., Karawajczyk, A., Zoll, J., Melchers, W. J. G., & Verweij, P. E. (2013). Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cit320

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.